MCRB

1.2406.77%
CM

Chris McChalicher

Executive VP & CTO

Mr. Chris McChalicher is Executive Vice President & Chief Technology Officer of Seres Therapeutics, Inc. since 2026 and served as its Senior VP of Manufacturing, Quality and Process Development until 2026. Mr. McChalicher is the Senior Vice President for Manufacturing, Quality and Process Development at Seres Therapeutics. He has over several years of research and development experience supporting pharmaceutical and industrial biotechnology programs. He has been with Seres since 2013, leading process development for VOWST™ (formerly SER-109) to BLA approval in 2023 and has led the CMC development of 5 additional products to early-phase clinical trials. Prior to Seres, Chris led research in upstream and downstream bioprocessing, enzymatic catalysis and computational biology for manufacture of biomaterials and small molecules, with product applications in the pharmaceutical, fuel and chemical feedstock industries. He is the inventor on 2 awarded US patents and has co-authored over 15 peer-reviewed papers. Chris earned a degree in chemical engineering from the University of Delaware and has held a 3M Science and Technology fellowship at the University of Minnesota.

Positions